# UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH: Phase 1 clinical trial of complement inhibition in primary graft dysfunction after lung transplantation

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH |
| Location | SALT LAKE CITY, UT |
| Project | Phase 1 clinical trial of complement inhibition in primary graft dysfunction after lung transplantation |
| Project number | 1R61HL187358-01 |
| Mechanism | R61 |
| Institute | National Heart Lung and Blood Institute |
| Award | $397,615 |
| Awarded | 2026-08-27 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | LL8GLEVH6MG3 |

## Why this score
- Award of $397,615.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11424576). Last refreshed: 2026-11-06T02:40:29.395Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.